Clinical trial
Improving Metabolism With HDL Cholesterol
NCT00395148 · Bayside Health, Other · Completed
Key facts
| NCT number | NCT00395148 |
|---|---|
| Title | Improving Metabolism With HDL Cholesterol |
| Official title | A Novel Mechanism Mediating Anti-atherosclerotic and Metabolic Actions of HDL Cholesterol |
| Lead sponsor | Bayside Health, Other |
| Collaborators | Baker Heart Research Institute |
| Status | Completed |
| Study type | Interventional |
| Conditions | Heart Disease, Diabetes |
| Intervention type | Drug |
| Interventions | rHDL |
| Enrollment | 13 |
| Start date | Mar 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Nov 2, 2006 |
| Last update posted | May 10, 2011 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: